Your browser doesn't support javascript.
loading
Analysing cerebrospinal fluid with explainable deep learning: From diagnostics to insights.
Schweizer, Leonille; Seegerer, Philipp; Kim, Hee-Yeong; Saitenmacher, René; Muench, Amos; Barnick, Liane; Osterloh, Anja; Dittmayer, Carsten; Jödicke, Ruben; Pehl, Debora; Reinhardt, Annekathrin; Ruprecht, Klemens; Stenzel, Werner; Wefers, Annika K; Harter, Patrick N; Schüller, Ulrich; Heppner, Frank L; Alber, Maximilian; Müller, Klaus-Robert; Klauschen, Frederick.
Afiliación
  • Schweizer L; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Seegerer P; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kim HY; Machine-Learning Group, Department of Software Engineering and Theoretical Computer Science, Technische Universität Berlin, Berlin, Germany.
  • Saitenmacher R; Aignostics GmbH, Berlin, Germany.
  • Muench A; Systems Medicine of Infectious Disease, Robert Koch Institute, Berlin, Germany.
  • Barnick L; Machine-Learning Group, Department of Software Engineering and Theoretical Computer Science, Technische Universität Berlin, Berlin, Germany.
  • Osterloh A; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Dittmayer C; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jödicke R; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Pehl D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Reinhardt A; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Ruprecht K; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Stenzel W; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wefers AK; Department of Pathology, Vivantes Hospitals Berlin, Berlin, Germany.
  • Harter PN; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Schüller U; Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Heppner FL; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Alber M; Institute of NeuropathologyUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Müller KR; Neurological Institute (Edinger Institute), Goethe University, Frankfurt am Main, Germany.
  • Klauschen F; Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany.
Neuropathol Appl Neurobiol ; 49(1): e12866, 2023 02.
Article en En | MEDLINE | ID: mdl-36519297
ABSTRACT

AIM:

Analysis of cerebrospinal fluid (CSF) is essential for diagnostic workup of patients with neurological diseases and includes differential cell typing. The current gold standard is based on microscopic examination by specialised technicians and neuropathologists, which is time-consuming, labour-intensive and subjective.

METHODS:

We, therefore, developed an image analysis approach based on expert annotations of 123,181 digitised CSF objects from 78 patients corresponding to 15 clinically relevant categories and trained a multiclass convolutional neural network (CNN).

RESULTS:

The CNN classified the 15 categories with high accuracy (mean AUC 97.3%). By using explainable artificial intelligence (XAI), we demonstrate that the CNN identified meaningful cellular substructures in CSF cells recapitulating human pattern recognition. Based on the evaluation of 511 cells selected from 12 different CSF samples, we validated the CNN by comparing it with seven board-certified neuropathologists blinded for clinical information. Inter-rater agreement between the CNN and the ground truth was non-inferior (Krippendorff's alpha 0.79) compared with the agreement of seven human raters and the ground truth (mean Krippendorff's alpha 0.72, range 0.56-0.81). The CNN assigned the correct diagnostic label (inflammatory, haemorrhagic or neoplastic) in 10 out of 11 clinical samples, compared with 7-11 out of 11 by human raters.

CONCLUSIONS:

Our approach provides the basis to overcome current limitations in automated cell classification for routine diagnostics and demonstrates how a visual explanation framework can connect machine decision-making with cell properties and thus provide a novel versatile and quantitative method for investigating CSF manifestations of various neurological diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aprendizaje Profundo Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Neuropathol Appl Neurobiol Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aprendizaje Profundo Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Neuropathol Appl Neurobiol Año: 2023 Tipo del documento: Article País de afiliación: Alemania